BioLine Rx’s Bold Move: How a Strategic Partnership Could Redefine Its Future Trajectory
BioLine Rx Ltd has secured a transformative licensing deal with AirMed Limited, gaining a $10 million upfront payment and potential $87 million in commercial milestones. An additional $9 million equity…